{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:36:34Z","timestamp":1791999394075,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.iac.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T09:51:41Z","timestamp":1537523501000},"page":"679-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Biomarkers in Chronic Rhinosinusitis with Nasal Polyps"],"prefix":"10.1016","volume":"38","author":[{"given":"Alan D.","family":"Workman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kohanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaip.2016.05.004","article-title":"Phenotypes and emerging endotypes of chronic rhinosinusitis","volume":"4","author":"Bachert","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2018.06.006_bib3","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1398-9995.2011.02709.x","article-title":"Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe","volume":"67","author":"Jarvis","year":"2012","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11882-015-0531-3","article-title":"Remodeling and repair in rhinosinusitis","volume":"15","author":"Watelet","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1067\/mai.2001.116428","article-title":"GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone","volume":"108","author":"Hamilos","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2012.01.079","article-title":"Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy","volume":"129","author":"Wen","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2018.06.006_bib10","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/lary.24154","article-title":"Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil","volume":"123","author":"Ikeda","year":"2013","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2018.06.006_bib12","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s00405-014-3456-x","article-title":"Endoglin (CD105) expression in sinonasal polyposis","volume":"272","author":"Ottaviano","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"10.1016\/j.iac.2018.06.006_bib13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.mlg.0000147917.43615.c0","article-title":"Molecular and cellular staging for the severity of chronic rhinosinusitis","volume":"114","author":"Kountakis","year":"2004","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.otohns.2009.10.005","article-title":"Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery","volume":"142","author":"Soler","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jaip.2017.04.009","article-title":"Lack of efficacy of symptoms and medical history in distinguishing the degree of eosinophilia in nasal polyps","volume":"5","author":"Steinke","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.iac.2018.06.006_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00405-014-2910-0","article-title":"Clinical characteristics and surrogate markers of eosinophilic chronic rhinosinusitis in Southern China","volume":"271","author":"Zuo","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2016.06.066","article-title":"Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps","volume":"139","author":"Chen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"AB238","key":"10.1016\/j.iac.2018.06.006_bib19","article-title":"Allergic sensitization, high local IL-5 and IgE predict surgical outcome 12 years after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"135","author":"Gevaert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/alr.21298","article-title":"Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression","volume":"4","author":"Wise","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.iac.2018.06.006_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.06.006_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2500\/ajra.2015.29.4176","article-title":"Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis","volume":"29","author":"Lam","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/alr.21082","article-title":"Clinical severity and epithelial endotypes in chronic rhinosinusitis","volume":"3","author":"Lam","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.anai.2017.07.012","article-title":"Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: a pilot study","volume":"119","author":"Chen","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00405-016-4260-6","article-title":"The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps","volume":"274","author":"Ozturan","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10056","key":"10.1016\/j.iac.2018.06.006_bib29","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jaip.2017.05.007","article-title":"Nasal polyps and biomarkers","volume":"5","author":"Naclerio","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10039","key":"10.1016\/j.iac.2018.06.006_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.iac.2018.06.006_bib35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib36","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.01.003","article-title":"IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis","volume":"135","author":"Shin","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2018.06.006_bib37","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1002\/lary.24305","article-title":"Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls","volume":"123","author":"Oyer","year":"2013","journal-title":"Laryngoscope"},{"issue":"1519","key":"10.1016\/j.iac.2018.06.006_bib38","first-page":"64","article-title":"Dupilumab (Dupixent) for moderate to severe atopic dermatitis","volume":"59","year":"2017","journal-title":"Med Lett Drugs Ther"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jaci.2015.09.005","article-title":"Association of periostin expression with eosinophilic inflammation in nasal polyps","volume":"136","author":"Wang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib40","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1038\/s41598-017-08375-2","article-title":"The role of periostin in the occurrence and progression of eosinophilic chronic sinusitis with nasal polyps","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib41","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2016.09.026","article-title":"Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps","volume":"139","author":"Kim","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/alr.21004","article-title":"Regional expression of epithelial MDR1\/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis","volume":"2","author":"Bleier","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.iac.2018.06.006_bib43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/alr.21176","article-title":"P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps","volume":"3","author":"Feldman","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib44","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/lary.26249","article-title":"Secreted P-glycoprotein is a noninvasive biomarker of chronic rhinosinusitis","volume":"127","author":"Nocera","year":"2017","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaci.2016.11.014","article-title":"Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps","volume":"140","author":"Miyake","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.01.043","article-title":"Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression","volume":"131","author":"Hulse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaci.2009.10.072","article-title":"Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps","volume":"125","author":"Peters","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib49","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2011.08.037","article-title":"Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps","volume":"128","author":"Tan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2500\/ajr.2007.21.3092","article-title":"Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis","volume":"21","author":"Goncalves","year":"2007","journal-title":"Am J Rhinol"},{"issue":"7","key":"10.1016\/j.iac.2018.06.006_bib51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2222.2008.03006.x","article-title":"Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis","volume":"38","author":"Delclaux","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2500\/ajra.2017.31.4480","article-title":"Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps","volume":"31","author":"Liu","year":"2017","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib53","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2500\/ajra.2014.28.3984","article-title":"Nasal and exhaled nitric oxide in chronic rhinosinusitis with polyps","volume":"28","author":"Jeong","year":"2014","journal-title":"Am J Rhinol Allergy"},{"issue":"10","key":"10.1016\/j.iac.2018.06.006_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/alr.21598","article-title":"Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis","volume":"5","author":"Lee","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"10.1016\/j.iac.2018.06.006_bib55","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1073\/pnas.0911934107","article-title":"Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals","volume":"107","author":"Tizzano","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"11","key":"10.1016\/j.iac.2018.06.006_bib56","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1172\/JCI64240","article-title":"T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection","volume":"122","author":"Lee","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/MMBR.05007-11","article-title":"The multiple signaling systems regulating virulence in Pseudomonas aeruginosa","volume":"76","author":"Jimenez","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5944","key":"10.1016\/j.iac.2018.06.006_bib58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1126\/science.1173869","article-title":"Motile cilia of human airway epithelia are chemosensory","volume":"325","author":"Shah","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.iac.2018.06.006_bib59","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI72094","article-title":"Bitter and sweet taste receptors regulate human upper respiratory innate immunity","volume":"124","author":"Lee","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/alr.21253","article-title":"The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery","volume":"4","author":"Adappa","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.iac.2018.06.006_bib61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/alr.21803","article-title":"Correlation of T2R38 taste phenotype and in\u00a0vitro biofilm formation from nonpolypoid chronic rhinosinusitis patients","volume":"6","author":"Adappa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/alr.21269","article-title":"The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome","volume":"4","author":"Zhang","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2018.06.006_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2017.09.014","article-title":"Bitter and sweet taste tests are reflective of disease status in chronic rhinosinusitis","author":"Workman","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cea.12666","article-title":"A\u00a0comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS)","volume":"46","author":"Mahdavinia","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2018.06.006_bib65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2334-13-210","article-title":"The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection","volume":"13","author":"Boase","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.iac.2018.06.006_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/alr.21871","article-title":"Evidence of microbiota dysbiosis in chronic rhinosinusitis","volume":"7","author":"Hoggard","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40168-017-0266-6","article-title":"Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences","volume":"5","author":"Cope","year":"2017","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/alr.21517","article-title":"Staphylococcus aureus impairs the airway epithelial barrier in\u00a0vitro","volume":"5","author":"Malik","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"10.1016\/j.iac.2018.06.006_bib69","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1398-9995.2012.02848.x","article-title":"Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis","volume":"67","author":"Seshadri","year":"2012","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/alr.21469","article-title":"Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment","volume":"5","author":"Oakley","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2018.06.006_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib72","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaci.2004.04.052","article-title":"Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray","volume":"114","author":"Liu","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.06.006_bib73","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaci.2013.06.010","article-title":"Forkhead box protein 3 in human nasal polyp regulatory T\u00a0cells is regulated by the protein suppressor of cytokine signaling 3","volume":"132","author":"Lan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2018.06.006_bib74","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/000348941112001203","article-title":"Chronic rhinosinusitis with nasal polyps: a proteomic analysis","volume":"120","author":"Upton","year":"2011","journal-title":"Annals of Otology, Rhinology & Laryngology"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib75","doi-asserted-by":"crossref","first-page":"AB179","DOI":"10.1016\/j.jaci.2016.12.585","article-title":"In-depth High-resolution Proteomic Analysis Using Nasal Secretions form Chronic Rhinosinusitis and Nasal Polyps","volume":"139","author":"Lee","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.06.006_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4193\/Rhino15.291","article-title":"Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps","volume":"55","author":"Pinto Bezerra Soter","year":"2017","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib78","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","article-title":"Oral steroids and doxycycline: two different approaches to treat nasal polyps","volume":"125","author":"Van Zele","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.06.006_bib79","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2015.01.043","article-title":"Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease","volume":"136","author":"Pothoven","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.06.006_bib80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.23610","article-title":"Role of frontal sinus surgery in nasal polyp recurrence","volume":"123","author":"Bassiouni","year":"2013","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.iac.2018.06.006_bib81","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/alr.21496","article-title":"Identification of chronic rhinosinusitis phenotypes using cluster analysis","volume":"5","author":"Soler","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.iac.2018.06.006_bib82","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2015.11.019","article-title":"Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis","volume":"137","author":"Soler","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.06.006_bib83","article-title":"Clinical phenotypes of nasal polyps and comorbid asthma based on cluster analysis of disease history","author":"Wu","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:11Z","timestamp":1760179331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856118300602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0889856118300602"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2018.06.006","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Chronic Rhinosinusitis with Nasal Polyps","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}